Hepatic Fibrosis Clinical Trials

A listing of Hepatic Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 6 clinical trials
Study of Obeticholic Acid OCA Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

Obecholic acid is a modified bile acid and Farnesoid X receptor (FXR) agonist. FXR is a key regulator of bile acid synthesis and transport. Bile acids are used by the body to help with digestion. Conventional therapy with obecholic acid will improve liver function of patients with PBC.

biopsy of liver
obeticholic acid
bile acid
antimitochondrial antibody
  • 29 Jul, 2021
  • 1 location
Characterization and Pathogenesis of ACLF

groups. SAPIENT = Sepsis ACLF patients, to investigate the differences between ACLF and sepsis in cirrhosis PROACT = Portal mediators as ACLF Targets, to assess portal venous

  • 30 Jul, 2021
  • 1 location
Decompensation of Cirrhosis and Iron Metabolism

Iron is a crucial metal whose metabolism is tightly regulated. Iron deficiency or iron overload are both deleterious at the cellular, organic and systemic levels. In line with the major role of the liver in iron homeostasis, links between iron metabolism and acute on chronic liver failure have been highlighted. …

acute on chronic liver failure
gastric varices
  • 27 Jul, 2021
  • 1 location
Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients

(Brief evaluation of alcohol related neuropsychological impairment). However, none of these tools have been evaluated in patients with alcoholic cirrhosis. Indeed, some studies have suggested

biopsy of liver
alcoholic cirrhosis
  • 24 Jul, 2021
  • 1 location
Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC

patients with hepatic fibrosis. Therefore, this study explored the application value of CEUS Li-RADS in liver focal lesions in patients with non-high risk factors for hepatocellular carcinoma.

  • 26 Jul, 2021
  • 10 locations
Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation

continuously increasing annual number of transplantations, an observation partly explained by an endemic ESLD etiology in the United States, the obesity-related non-alcoholic steatohepatitis (NASH) cirrhosis

  • 31 Jul, 2021
  • 1 location